Glenmark Pharma rallied nearly 9% to Rs 1,763.90 after the US drug regulator issued Form 483 with zero observations for its formulation manufacturing facility in Aurangabad.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
